Multivariable Analysis of Clinical Indicators and Marrow Status by PET/BMB on Survival
| OS | EFS | |||
| Variable | HR | P | HR | P |
| Age > 60 y | 1.51 (0.82–2.77) | 0.18 | 0.96 (0.60–1.54) | 0.86 |
| Ann Arbor stage III/IV | 1.16 (0.54–2.50) | 0.70 | 1.21 (0.70–2.08) | 0.50 |
| >1 extranodal site | 1.27 (0.66–2.46) | 0.47 | 1.20 (0.73–1.96) | 0.47 |
| LDH level > normal | 2.42 (1.26–4.67) | 0.01 | 2.22 (1.39–3.56) | <0.01 |
| Eastern Cooperative Oncology Group performance status ≥ 2 | 1.55 (0.79–3.05) | 0.21 | 1.56 (0.93–2.64) | 0.10 |
| PET–/BMB+ | 0.49 (0.07–3.68) | 0.49 | 1.13 (0.40–3.20) | 0.83 |
| PET+/BMB– | 0.74 (0.33–1.66) | 0.46 | 0.68 (0.37–1.27) | 0.23 |
| PET+/BMB+ | 2.26 (1.02–5.03) | 0.05 | 1.61 (0.84–3.10) | 0.15 |
Data in parentheses are 95% CIs.